#polypeptidegroup — Public Fediverse posts

https://www.europesays.com/ch/106658/ Samsung Biologics Acquires Swiss CDMO for approximately $1.8 Billion, Making a Major Push into the Obesity Drug Market — BigGo Finance #CDMO #EliLilly #GLP1 #JohnRim #KiwoomSecurities #mounjaro #NHInvestment&Securities #NovoNordisk #ObesityTreatment #Peptide #PolyPeptideGroup #SamsungBiologics #Swiss #Switzerland #Wegovy

Samsung Biologics Acquires Swiss CDMO for approximately $1.8 Billion, Making a Major Push into the Obesity Drug Market — BigGo Finance

Samsung Biologics (207940) is investing approximately 2.7 trillion won (approximately $1.8 billion) to acquire PolyPeptide Group, a global…
#EuropeSays #Korea #KR #SamsungBiologics #CDMO #EliLilly #GLP-1 #JohnRim #KiwoomSecurities #Mounjaro #NHInvestment&Securities #NovoNordisk #obesitytreatment #peptide #PolyPeptideGroup #Samsung #Wegovy
https://www.europesays.com/korea/94800/

https://www.europesays.com/ch/106156/ Samsung Biologics Acquires Swiss PolyPeptide Group for approximately $1.8 Billion, Targeting Obesity Drug Market — BigGo Finance #CDMO #DraupnirHolding #EliLilly #Ferring #GLP1 #JohnRim #PeterWilden #PolyPeptideGroup #SamsungBiologics #SIXSwissExchange #Swiss #Switzerland

Samsung Biologics Bets $1.8 Billion on ‘K-Obesity Drug’ Play with Swiss PolyPeptide Acquisition — BigGo Finance

Samsung Biologics has thrown its hat into the rapidly growing global obesity treatment market, committing 2.7 trillion won…
#EuropeSays #Korea #KR #SamsungBiologics #CDMO #EliLilly #GLP-1 #JohnRim #LeeJae-yong #Mounjaro #NovoNordisk #peptide #PolyPeptideGroup #Samsung #SamsungElectronics #Wegovy
https://www.europesays.com/korea/93098/

https://www.europesays.com/ch/105831/ Samsung Biologics Bets $1.8 Billion on ‘K-Obesity Drug’ Play with Swiss PolyPeptide Acquisition — BigGo Finance #CDMO #EliLilly #GLP1 #JohnRim #LeeJaeYong #mounjaro #NovoNordisk #Peptide #PolyPeptideGroup #SamsungBiologics #SamsungElectronics #Swiss #Switzerland #Wegovy

Why Samsung’s 2.7 Trillion Won Deal Signals Its Galaxy Healthcare Push

[CAPTIONS] Samsung Electronics Chairman Lee Jae-yong. Yonhap News Samsung Biologics’ move into the largest merger and acquisition in…
#EuropeSays #Korea #KR #SamsungBiologics #digitalhealthcare #Galaxyecosystem #GLP-1peptidedrugs #PolyPeptideGroup #Samsung #SamsungHealth #SamsungMedison #Xealth
https://www.europesays.com/korea/92982/

Samsung Biologics Seals 2.7 Trillion Won Deal for Wegovy Ingredient Maker

Samsung Biologics announced on the 20th that it will acquire peptide specialist PolyPeptide Group for 2.7 trillion won.…
#EuropeSays #Korea #KR #SamsungBiologics #CDMO #KoreapharmaM&A #NovoNordisk #peptidemanufacturing #PolyPeptideGroup #Samsung #Saxenda #Wegovy
https://www.europesays.com/korea/92914/

Samsung Biologics Acquires Swiss Peptide CDMO PolyPeptide Group for approximately $1.8 Billion — BigGo Finance

Samsung Biologics (207940) has placed a major bet on capturing the global peptide contract development and manufacturing organization…
#EuropeSays #Korea #KR #Samsung #DraupnirHolding #GLP-1 #ObesityTreatments #PeptideCDMO #PolyPeptideGroup #SamsungBiologics #SamsungGroup #Switzerland
https://www.europesays.com/korea/92708/

https://www.europesays.com/ch/105743/ Samsung Biologics Acquires Swiss Peptide CDMO PolyPeptide Group for approximately $1.8 Billion — BigGo Finance #DraupnirHolding #GLP1 #ObesityTreatments #PeptideCDMO #PolyPeptideGroup #Samsung #SamsungBiologics #Swiss #Switzerland

Switzerland: Samsung Biologics to acquire PolyPeptide for US$1.8bn

Listed South Korean CDMO, Samsung Biologics, is acquiring all shares in SIX-listed PolyPeptide, a specialised CDMO for peptide-based…
#Switzerland #CH #Europe #Europa #EU #Homburger #JohnRim #MorganStanley #Nachrichten #Nouvelles #PeterWilden #PolyPeptideGroup #SamsungBiologics #schweiz #Suisse #switzerland
https://www.europesays.com/3142877/

Samsung Biologics To Acquire PolyPeptide For CHF 1.46 Billion

Samsung Biologics has launched an all-cash public tender offer to acquire PolyPeptide Group for approximately CHF 1.46 billion.…
#EuropeSays #Korea #KR #SamsungBiologics #PolyPeptideGroup #Samsung
https://www.europesays.com/korea/92474/

Switzerland: Samsung Biologics to acquire PolyPeptide for US$1.8bn

Listed South Korean CDMO, Samsung Biologics, is acquiring all shares in SIX-listed PolyPeptide, a specialised CDMO for peptide-based…
#EuropeSays #Korea #KR #SamsungBiologics #Homburger #JohnRim #MorganStanley #PeterWilden #PolyPeptideGroup #Samsung #Switzerland
https://www.europesays.com/korea/92404/

https://www.europesays.com/ch/105623/ Switzerland: Samsung Biologics to acquire PolyPeptide for US$1.8bn #Homburger #JohnRim #MorganStanley #PeterWilden #PolyPeptideGroup #SamsungBiologics #Switzerland

Samsung Biologics to Acquire Peptide CDMO for 2.7 Trillion Won

A view of Samsung Biologics’ Plant 4. Photo courtesy of Samsung Biologics Samsung Biologics (207940.KS) is moving to…
#EuropeSays #Korea #KR #Samsung #biopharmaceuticals #contractmanufacturing #PeptideCDMO #PolyPeptideGroup #SamsungBiologics #SamsungGroup #Swisspharmaceuticalacquisition #tenderoffer
https://www.europesays.com/korea/91816/

Samsung Biologics to Acquire Swiss Peptide CDMO for approximately $1.8 Billion, Targeting Obesity Drug Market — BigGo Finance

Samsung Biologics (207940.KS) announced on the 20th that it will acquire PolyPeptide Group, a global peptide contract development…
#EuropeSays #Korea #KR #Samsung #207940.KS #GLP-1 #JohnRim #obesitytreatment #PeptideCDMO #PeterWilden #PolyPeptideGroup #SamsungBiologics #SamsungGroup #Switzerland
https://www.europesays.com/korea/91608/

https://www.europesays.com/ch/105401/ Samsung Biologics to Acquire Swiss Peptide CDMO for approximately $1.8 Billion, Targeting Obesity Drug Market — BigGo Finance #207940KS #GLP1 #JohnRim #ObesityTreatment #PeptideCDMO #PeterWilden #PolyPeptideGroup #SamsungBiologics #Swiss #Switzerland